Christoph Schubart

5PUBLICATIONS
22CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?

Christoph Schubart, Lars Tögel, Maria Giulia Carta

|Dec 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center.

Lars Tögel, Christoph Schubart, Sebastian Lettmaier

|Oct 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.

Florian Lüke, Florian Haller, Kirsten Utpatel

|Oct 13, 2021
MET Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting.

Christoph Schubart, Robert Stöhr, Lars Tögel

|May 26, 2019
RELMα-expressing macrophages protect against fatal lung damage and reduce parasite burden during helminth infection.

Branislav Krljanac, Christoph Schubart, Ronald Naumann

Pageof 1

Frequent Collaborators

1 joint publications

Branislav Krljanac

1 joint publications

Stefan Wirtz

1 joint publications

David Voehringer

1 joint publications

Lars Tögel